Amryt Pharma Holdings Ltd
LSE:AMYT
Amryt Pharma Holdings Ltd
Cash from Financing Activities
Amryt Pharma Holdings Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Amryt Pharma Holdings Ltd
LSE:AMYT
|
Cash from Financing Activities
$26m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Cash from Financing Activities
-£6.4B
|
CAGR 3-Years
15%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
1%
|
|
AstraZeneca PLC
LSE:AZN
|
Cash from Financing Activities
-$2.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
2%
|
|
Indivior PLC
LSE:INDV
|
Cash from Financing Activities
-$62m
|
CAGR 3-Years
-78%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Cash from Financing Activities
-$337m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-4%
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Cash from Financing Activities
£316.5m
|
CAGR 3-Years
39%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
See Also
What is Amryt Pharma Holdings Ltd's Cash from Financing Activities?
Cash from Financing Activities
26m
USD
Based on the financial report for Dec 31, 2020, Amryt Pharma Holdings Ltd's Cash from Financing Activities amounts to 26m USD.
What is Amryt Pharma Holdings Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-3%
Over the last year, the Cash from Financing Activities growth was -61%. The average annual Cash from Financing Activities growth rates for Amryt Pharma Holdings Ltd have been -3% over the past three years .